Franklin Resources Inc. raised its stake in shares of Genpact Limited (NYSE:G - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,203,956 shares of the business services provider's stock after purchasing an additional 55,771 shares during the period. Franklin Resources Inc. owned 2.38% of Genpact worth $180,560,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. CIBC Asset Management Inc grew its stake in Genpact by 5.5% in the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider's stock valued at $244,000 after buying an additional 297 shares during the last quarter. Tealwood Asset Management Inc. lifted its position in shares of Genpact by 1.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider's stock worth $1,059,000 after purchasing an additional 339 shares during the last quarter. UMB Bank n.a. boosted its stake in Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares during the period. OneAscent Wealth Management LLC grew its holdings in Genpact by 5.5% in the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock valued at $360,000 after buying an additional 439 shares during the last quarter. Finally, Blue Trust Inc. increased its position in Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after buying an additional 441 shares during the period. Institutional investors own 96.03% of the company's stock.
Insider Activity
In other news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company's stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.
Analysts Set New Price Targets
Several research firms recently weighed in on G. Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $48.44.
Read Our Latest Research Report on G
Genpact Price Performance
Shares of NYSE:G traded down $1.83 during midday trading on Friday, reaching $47.08. The company's stock had a trading volume of 2,182,743 shares, compared to its average volume of 1,347,002. The business's fifty day simple moving average is $51.20 and its 200-day simple moving average is $45.44. The company has a market capitalization of $8.27 billion, a P/E ratio of 16.58, a P/E/G ratio of 1.84 and a beta of 1.06. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.44%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is presently 23.94%.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report